Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...
- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of Citius' novel...
Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
As posted on SeekingAlpha.
Adding Sekur Private Data (SWISF) to Watch List.
WhatsApp & Gmail Competitor That's Secure.
LIVE QUOTE
Our First Cyber-Security Play in a Long Time. Looks Interesting.
Sekur is a private and secure messaging and email...
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...
Medtech Incubator in Final Stages of Launch.
TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner and Attract...
Revive (RVVTF) Hits a Snag?
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
First our summary."FDA provided communication that the amended protocol is still under...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
We're adding Citius Pharma to the Watch...
Adding Principal Solar (PSWW) to Watch List.
LIVE QUOTE
Principal Solar Website
And we found another Incubator! This one acquiring stakes in technologies that support next-generation opportunities in traditional, renewable, and clean energy...
Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.
If we average out the two most recent price targets this month, we come out with a potential gain of 337% and that ain't...
Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...
We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical Start-Up American...















